AmSurg receives average "buy" rating

Eleven analyst firms have given AmSurg stock an average rating of "buy," according to a report from The Legacy.

AmSurg stock has an average 12-month price target of $67.45. The company's stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast